Navigation Links
New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinson's Clinical Trials
Date:3/19/2008

NEW YORK, March 19 /PRNewswire-USNewswire/ -- As part of its ongoing efforts to develop research tools that can speed the availability of life-transforming treatments for Parkinson's disease, The Michael J. Fox Foundation announced the launch of its Web-based Clinical Assessment Program. Under this initiative, the Foundation seeks to drive the creation and testing of Web-based tools that would allow any patient with a personal computer and an Internet connection to participate in clinical research from the comfort of their own home.

Historically, clinical research in Parkinson's and other diseases has required patients to travel, often several hours or more, for in-person interviews, examinations and tests. This is a burden for anyone living with a disease, and takes an incredible toll on people with PD, where unpredictable motor and non-motor effects, as well as the efficacy and side effects of medication, vary from day to day.

"A Web-based clinical assessment can never entirely take the place of face-to-face interactions between patients and researchers," said Katie Hood, CEO of MJFF. "But as a supplemental measure it could heighten efficiency and help speed progress toward new treatments by increasing, for a given trial, the amount and breadth of information from which to draw conclusions."

Added Todd Sherer, PhD, the Foundation's vice president of research programs: "In addition to increasing the participation of individuals who might otherwise not realistically be able to take part due to travel, a Web-based clinical assessment could provide a more complete picture of symptoms by introducing the ability to test certain functions at home and throughout the day."

Ideal applications for this initiative will focus on three deliverables: the development of an assessment tool that will be available to patients through the Internet; the creation of a technological infrastructure through which patients will be able to access t
'/>"/>

SOURCE Michael J. Fox Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
2. Michael J. Fox Foundation Commits Up to $3 Million for Clinical Trials That Can Improve Treatment of Parkinsons Disease
3. Kevin McHale Instrumental in Forming the Help Me Hear Foundation
4. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
5. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
6. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
7. The Oral Cancer Foundation Urges HPV Vaccination for Males
8. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
9. Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium
10. Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
11. Five Clinical Studies to Receive $2.5 Million Under Foundations 2007 Clinical Discovery Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Cardiovascular Devices: Technologies an...com/p0166823/Cardiovascular-Devices-Technologies-a...e view of the cardiovascular devices industry on a...major types of cardiovascular diagnostic equipment...
(Date:12/2/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Hemoglobin A1c Monitoring - Global Marke...230/Hemoglobin-A1c-Monitoring---Global-Market-Tren...he need for effective therapy to manage diabetes h...r monitoring the treatment efficiency of the disea...
(Date:12/2/2009)...Newswire-USNewswire/ -- Jupiter Medical Center h...c tools available into its imaging program, the ne...e system delivers highly detailed images of the hu...nd unique applications, including dual breast scan...s with renal dysfunction. This results in shorter...
Breaking Medicine Technology:Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 2Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 3Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 4Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 5Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 6Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 7Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 8Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 9Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 10Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 11Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 12Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 2Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 3Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 4Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 5Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 6Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 7Jupiter Medical Center Announces New High-Definition MRI System 2PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June 12569 1PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June 12569 2Tribe Makes Payment of 24945 000 to Assist County With Emergency Services and Fire Protection 48489 1Tribe Makes Payment of 24945 000 to Assist County With Emergency Services and Fire Protection 48489 2Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 1Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 2Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 3
...tion leadership and long-term commitment to hepati...chering-Plough Corporation (NYSE: SGP ) today pr...nvestigational oral hepatitis C protease inhibitor...believes boceprevir has the potential to be a firs...r treating chronic hepatitis C. The company also ...
...chering-Plough Corporation (NYSE: SGP ) today re...denosine2a receptor antagonist, met the primary en...s suffering from moderate to severe Parkinson,s di... involuntary movements (dyskinesias). The trial r...R&D Update meeting being hosted for analysts a...
Other Medicine Technology:Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 2Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 3Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 4
(Date:12/3/2009)...ire/ -- A majority of Americans support a "public ... lack confidence that the cost, quality, value or ...next year, according to a survey released today by...spondents said they believe a public option should...n. Only about one in five, however, believes the c...
(Date:12/2/2009)... -- Reportlinker.com announces that a new market r..., Renal Disease Treatments: Products and Therapie...al-Disease-Treatments-Products-and-Therapies.html ...nd services, providing data for 2008 and estimates...ound annual growth rates (CAGRs) from 2009 to 2014...
(Date:12/2/2009)...Newswire-FirstCall/ -- The City of Seoul, the Com...e and Qualcomm Incorporated (Nasdaq: QCOM ), thro...nced the expansion of a project that provides mobi..."Seoul Family Helper" program. This project suppl...senior citizens in order to provide healthcare rel...
(Date:12/2/2009)...ounter recent increases in longevity , ,... health of the U.S. population has improved over t... quit smoking in droves, but a new study suggests ...obesity rates among Americans don,t level off or d...esity continue unchanged, the average life expecta...
(Date:12/2/2009)...-USNewswire/ -- Huntington Memorial Hospital,s str... from the Joint Commission, designating the hospit... will join the network of "approved stroke center"..."This is a significant milestone for the hospital,...ena and its surrounding communities," said Arbi Oh...
Breaking Medicine News(10 mins):Health News:Thomson Reuters Survey: Most Americans Support Public Option in Healthcare Reform Legislation but Are Skeptical Healthcare Will Improve in 2010 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 3Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 4Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 5Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 6Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 7Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 8Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 9Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 10Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 2Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 3Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 4Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:Huntington Hospital Earns Designation as Primary Stroke Center 2
...ing Inc. (NYSE: BKD ) today announced that Mark...er, will make a presentation regarding the Company...Francisco, California on Tuesday, May 19, 2009, be...ebcast/jmp8/bkd/ as well as through the Investo...
...cational initiatives between the clinical staff at...their Partners program suggest that educational in... quality of care for cancer patients at community ...ymph nodes that were surgically removed in colorec...
...reast cancer patients , , THURSDAY, May 14...he nausea-easing powers of ginger that many grandm...the spice helped cancer patients who were undergoi...motherapy, and reduced nausea will lead to improve...
...c. (NYSE: HGR ) will replace Gevity HR Inc. (NAS...se of trading on a date to be announced. Gevity HR... Inc. in a transaction expected to close soon. , ...edic Group Inc. owns and operates orthotic and pro...
...ess, bus tour will be stopping in Utah throughout ...er to help uninsured and financially-struggling Ut...prescription medicines for free or nearly free. Wi...is raising awareness of patient assistance program...
...pproval of Prevacid OTC(R) 24HR, The Procter &... , (Photo: http://www.newscom.com/cgi-bin/prn...ctor and pharmacist recommended over-the-counter h...rket and since 2003, millions of consumers have ma...
Other Medicine News:Health News:Educational initiatives improve quality of care delivery 2Health News:Ginger Eases Nausea From Chemo 2Health News:Standard & Poor's Announces Changes to U.S. Index 2Health News:Partnership for Prescription Assistance Prepared to Help Utah Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Utah Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Utah Workers Hurt by Recession 4Health News:P&G Response to FDA Approval of Prevacid OTC(R) 24HR 2
Urocare® Vinyl Urinary Leg Bags - Medium with Twist Drain
Urocare® Vinyl Urinary Leg Bags - Large with Twist Drain
Urocare® Latex Urinary Leg Bag - Short-Wide
Urocare® Latex Urinary Leg Bag - Large
Medicine Products: